期刊文献+

Application of Near Infrared Diffuse Reflectance Spectroscopy with Radial Basis Function Neural Network to Determination of Rifampincin Isoniazid and Pyrazinamide Tablets 被引量:3

Application of Near Infrared Diffuse Reflectance Spectroscopy with Radial Basis Function Neural Network to Determination of Rifampincin Isoniazid and Pyrazinamide Tablets
下载PDF
导出
摘要 Partial least squares(PLS),back-propagation neural network(BPNN)and radial basis function neural network(RBFNN)were respectively used for estalishing quantative analysis models with near infrared(NIR)diffuse reflectance spectra for determining the contents of rifampincin(RMP),isoniazid(INH)and pyrazinamide(PZA)in rifampicin isoniazid and pyrazinamide tablets.Savitzky-Golay smoothing,first derivative,second derivative,fast Fourier transform(FFT)and standard normal variate(SNV)transformation methods were applied to pretreating raw NIR diffuse reflectance spectra.The raw and pretreated spectra were divided into several regions,depending on the average spectrum and RSD spectrum.Principal component analysis(PCA)method was used for analyzing the raw and pretreated spectra in different regions in order to reduce the dimensions of input data.The optimum spectral regions and the models' parameters were chosen by comparing the root mean square error of cross-validation(RMSECV)values which were obtained by leave-one-out cross-validation method.The RMSECV values of the RBFNN models for determining the contents of RMP,INH and PZA were 0.00288,0.00226 and 0.00341,respectively.Using these models for predicting the contents of INH,RMP and PZA in prediction set,the RMSEP values were 0.00266,0.00227 and 0.00411,respectively.These results are better than those obtained from PLS models and BPNN models.With additional advantages of fast calculation speed and less dependence on the initial conditions,RBFNN is a suitable tool to model complex systems. Partial least squares(PLS),back-propagation neural network(BPNN)and radial basis function neural network(RBFNN)were respectively used for estalishing quantative analysis models with near infrared(NIR)diffuse reflectance spectra for determining the contents of rifampincin(RMP),isoniazid(INH)and pyrazinamide(PZA)in rifampicin isoniazid and pyrazinamide tablets.Savitzky-Golay smoothing,first derivative,second derivative,fast Fourier transform(FFT)and standard normal variate(SNV)transformation methods were applied to pretreating raw NIR diffuse reflectance spectra.The raw and pretreated spectra were divided into several regions,depending on the average spectrum and RSD spectrum.Principal component analysis(PCA)method was used for analyzing the raw and pretreated spectra in different regions in order to reduce the dimensions of input data.The optimum spectral regions and the models' parameters were chosen by comparing the root mean square error of cross-validation(RMSECV)values which were obtained by leave-one-out cross-validation method.The RMSECV values of the RBFNN models for determining the contents of RMP,INH and PZA were 0.00288,0.00226 and 0.00341,respectively.Using these models for predicting the contents of INH,RMP and PZA in prediction set,the RMSEP values were 0.00266,0.00227 and 0.00411,respectively.These results are better than those obtained from PLS models and BPNN models.With additional advantages of fast calculation speed and less dependence on the initial conditions,RBFNN is a suitable tool to model complex systems.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2007年第5期518-523,共6页 高等学校化学研究(英文版)
基金 Supported by the Science Technology Development Project of Jilin Province,China(No.20020503-2).
关键词 利福平异烟肼 抗结核药 吡嗪酰胺 反射光谱分析 Rifampicin isoniazid and pyrazinamide tablets NIR diffuse reflectance spectroscopy Partial least square Back-propagation neural network Radial basis function neural network
  • 相关文献

参考文献19

  • 1Panchagnula R. , Agrawal S. , Int. J. Pharm. , 2004, 271, 1
  • 2Agrawal S., Kaur K. J., Singh I., et al., Int. J. Pharm. , 2002, 233, 169
  • 3Panchagnula R. , Sancheti P. , Rungta S. , et al. , Pharmacol. Res. , 2003, 48, 383
  • 4Patel Y. P. , Shah N. , Bhoir I. C. , et al. , J. Chromatogr. A, 1998, 828, 287
  • 5Acedo-Valenzuela M. I. , Espinosa-Mansilla A. , Pena A. M. ,et al. , Anal. Bioanal. Chem. , 2002, 374,432
  • 6Espinosa-Mansilla A. , Acedo-Valenzuela M. I. , Pena A. M. , et al. , Talanta, 2002, 58, 273
  • 7Argeka A. P., Kunjir S. S., Purandare K. S., J. Pharm. Biomed. Anal. , 1996, 4, 1645
  • 8Smith P. J. , van Dyk J. , Fredericks A. , Int. J. Tuberc. Lung. Dis. 1999, 3, 325
  • 9Dou Y., Sun Y., Ren Y. Q., et al., J. Pharm. Biomed. Anal. , 2005, 37, 543
  • 10Baratieri S. C. , Barbosa J. M. , Freitas M. P. , et al. , J. Pharm. Biomed. Anal. , 2006, 40, 51

同被引文献33

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部